GUTS vs. SMLR, NNOX, SMTI, STIM, SNWV, ZIMV, NVRO, TCMD, SKIN, and NYXH
Should you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Semler Scientific (SMLR), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), Nevro (NVRO), Tactile Systems Technology (TCMD), Beauty Health (SKIN), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.
Fractyl Health vs.
Fractyl Health (NASDAQ:GUTS) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, community ranking, analyst recommendations, valuation, media sentiment and institutional ownership.
49.4% of Semler Scientific shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Fractyl Health received 3 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 100.00% of users gave Fractyl Health an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote.
In the previous week, Semler Scientific had 1 more articles in the media than Fractyl Health. MarketBeat recorded 8 mentions for Semler Scientific and 7 mentions for Fractyl Health. Semler Scientific's average media sentiment score of 0.59 beat Fractyl Health's score of 0.29 indicating that Semler Scientific is being referred to more favorably in the news media.
Semler Scientific has higher revenue and earnings than Fractyl Health. Semler Scientific is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.
Fractyl Health currently has a consensus price target of $11.00, indicating a potential upside of 497.83%. Semler Scientific has a consensus price target of $71.00, indicating a potential upside of 58.16%. Given Fractyl Health's higher possible upside, equities research analysts plainly believe Fractyl Health is more favorable than Semler Scientific.
Fractyl Health has a beta of 0.1, suggesting that its stock price is 90% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500.
Semler Scientific has a net margin of 72.65% compared to Fractyl Health's net margin of -64,849.48%. Semler Scientific's return on equity of 50.77% beat Fractyl Health's return on equity.
Summary
Semler Scientific beats Fractyl Health on 11 of the 17 factors compared between the two stocks.
Get Fractyl Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fractyl Health Competitors List
Related Companies and Tools
This page (NASDAQ:GUTS) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy GUTS Stock Free GUTS Stock Alerts